Is AEON Biopharma, Inc. (AEON) undervalued? · P/E 0.0, $8.6M cap
AEON Biopharma, Inc. (AEON) is a biotechnology company listed on US.
This page asks whether AEON Biopharma, Inc. (AEON) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Without a cached income statement, “undervalued AEON” is a slogan. Wait for the print.
AEON currently screens at market cap $8.6M and trailing P/E 0.0. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new AEON 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare AEON to the stock page model before you treat a low multiple as a gift.
Not investment advice.